Background: To date, there is no effective cure for HIV-1. The ‘shock and kill’ approach aims to reactivate the reservoir and target its clearance via immune or therapeutic mechanisms. Beyond T cells, purging the reservoir after reactivation with HIV-specific antibodies that recruit the cytotoxic and antiviral activity of the innate immune system has not been assessed. It has been shown that functional antibodies have a protective effect in HIV-disease progression and were induced in the RV144 vaccine trial. Finding epitopes targeted by functional antibodies on reactivated latent cells could lead to the design of new therapeutic approaches to eradicate HIV reservoirs. Methodology: Latently HIV-1 infected cell lines (ACH2, J89GFP and U1), were treated for 24 hours with PHA or the histone deacetylase inhibitors (HDACi) vorinostat, panobinostat, or romidepsin and incubated with monoclonal antibodies (mAbs) to Env (n=30) for the detection of various epitopes on reactivated cells. Intracellular p24 or GFP and extracellular Env were detected with flow cytometry. An antibody dependent cellular phagocytosis (ADCP) assay was performed on reactivated ACH2 (Panobinostat). A monocytic cell line, THP-1, were stained by cell trace blue, while ACH2 cells were stained by CFSE and cultured for 4 hours in the presence of mAbs. Percentage phagocytosis was calculated as double positive cells over CFSE alone. Results: The HDACis, romidepsin and panobinostat induced HIV reactivation (p24 or GFP) to the highest levels in ACH2, followed by J89, and then U1 cells. Latency reversal in all cell types led to an upregulation of surface Env. Different epitopes were exressed on the cell surface as seen by the differential ability of the mAbs to recognize the reactived cells, with 2G12 recognizing the largest fraction of reactivated population. Moreover, antibody-coated reactivated ACH2 cells were efficiently phagocytosed by monocytic THP-1 cells. Interestingly, gp41 antibodies showed the most effective recruitment of ADCP, despite a delayed epitope expression. Finally, antibody mediated elimination of latently reactivated cells exhibited glycan dependent killing, with afucosylated antibodies exhibiting the strongest ADCP. Conclusions: Here we show that HDACi-reactivated latently infected cell lines robustly expressed Env on the cell surface. More critically, a clear hierarchy was observed among tested mAbs in their ability to recognize reactivated cells, and recruit innate effector activities that can promote efficient killing or eradication of the reservoir. These findings provide a critical footprint for epitopes that a therapeutic vaccine or passive transfer antibodies needs to target that could lead to the rapid elimination of the reservoir, providing a path to a functional cure.